Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Molecular Cancer Therapeutics|May 8, 2015
BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell VolumeNicholas Theodosakis, Matthew A Held, Alexander Marzuka-Alcala, et al.Cancer Research|November 23, 2016
Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast CancerVikram B Wali, Casey G Langdon, Matthew A Held, et al.Pigment Cell & Melanoma Research|April 10, 2015
The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitorsCasey G Langdon, Matthew A Held, James T Platt, et al.Cancer Discovery|December 15, 2012
Genotype-selective combination therapies for melanoma identified by high-throughput drug screeningMatthew A Held, Casey G Langdon, James T Platt, et al.Oncotarget|October 21, 2015
SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cellsCasey G Langdon, Norbert Wiedemann, Matthew A Held, et al.Molecular Cancer Therapeutics|March 16, 2017
Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation InhibitorCasey G Langdon, James T Platt, Robert E Means, et al.Cell Reports|December 16, 2017
Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient CareDavid P Kodack, Anna F Farago, Anahita Dastur, et al.Pageof 2